Caris Life Sciences to report Q2 2026 results on August 5
Caris Life Sciences will announce its Q2 2026 financial results on August 5, 2026, followed by a live webcast at 3:30 p.m. CT. The company, a TechBio firm specializing in precision medicine, will provide a replay on its investor relations website.
*this image is generated using AI for illustrative purposes only.
Caris Life Sciences (NASDAQ: CAI) will report its second quarter 2026 financial results on Wednesday, August 5, 2026. The announcement will be followed by a live webcast to discuss the performance, providing stakeholders with insights into the company's financial health and operational progress.
The webcast is scheduled to begin at 3:30 p.m. CT (4:30 p.m. ET). Investors and interested parties can access the live broadcast via the company's dedicated webcast link. A replay of the session will be made available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website.
Webcast Details
| Event | Details |
|---|---|
| Date | Wednesday, August 5, 2026 |
| Time | 3:30 p.m. CT (4:30 p.m. ET) |
| Live Webcast | https://edge.media-server.com/mmc/p/ff8xb4qs |
Caris Life Sciences is a leading TechBio company focused on developing and commercializing innovative solutions to transform healthcare. The company utilizes comprehensive molecular profiling, advanced AI, and machine learning to analyze the molecular complexity of disease. Headquartered in Irving, Texas, Caris operates in various international markets, including the U.S., Japan, and Switzerland.
What key financial metrics will investors be focusing on during the Q2 2026 earnings call?
How might Caris Life Sciences' AI and machine learning advancements impact its competitive position in the TechBio sector?
What potential market reactions could follow the release of Caris' Q2 2026 financial results?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
